In-depth immune profiling reveals advanced B- and T-cell differentiation to be associated with Th1-driven immune dysregulation in common variable immunodeficiencyShow others and affiliations
2023 (English)In: Clinical Immunology, ISSN 1521-6616, E-ISSN 1521-7035, Vol. 257, article id 109816Article in journal (Refereed) Published
Abstract [en]
Common variable immunodeficiency (CVID) is an inborn error of immunity characterized by low levels of an-tibodies. In addition to infections, many patients also suffer from T-helper 1-driven immune dysregulation, which is associated with increased mortality. The aim of this study was to perform in-depth characterization of the T and the B cell compartments in a well-defined cohort of patients affected by CVID and correlate the findings to the level of clinical immune dysregulation. We used mass cytometry, targeted proteomics, flow cytometry and functional assays to delineate the immunological phenotype of 15 CVID-affected patients with different levels of immune dysregulation. Unbiased clustering of T cell mass cytometry data correlated with CVID-related immune dysregulation and plasma protein profiles. Expanded CXCR3+ T-bet-expressing B cells correlated with effector memory CD4+ T cell clusters, and increased plasma levels of CXCR3-ligands. Our findings indicate an interplay between B cells and T cells in CVID-related immune dysregulation and provide a better understanding of the underlying pathological mechanisms.
Place, publisher, year, edition, pages
ACADEMIC PRESS INC ELSEVIER SCIENCE , 2023. Vol. 257, article id 109816
Keywords [en]
CVID; Inborn error of immunity; Immune dysregulation; Predominantly antibody deficiency; CXCR3; CD21 low B cells
National Category
Immunology in the medical area
Identifiers
URN: urn:nbn:se:liu:diva-199716DOI: 10.1016/j.clim.2023.109816ISI: 001111455900001PubMedID: 37918468OAI: oai:DiVA.org:liu-199716DiVA, id: diva2:1821518
Note
Funding Agencies|ALF Region Ostergotland, Sweden [1203, RO-96962]; Bertil and Ebon Norlins Foundation for Medical Research, Sweden [1203]
2023-12-202023-12-202024-09-19